Literature DB >> 16246026

Maintaining the protective variant surface glycoprotein coat of African trypanosomes.

G Rudenko1.   

Abstract

The African trypanosome Trypanosoma brucei has a precarious existence as an extracellular parasite of the mammalian bloodstream, where it is faced with continuous immune attack. Key to survival is a dense VSG (variant surface glycoprotein) coat, which is repeatedly switched during the course of a chronic infection. New data demonstrate a link between VSG synthesis and cell cycle progression, indicating that VSG is monitored during the trypanosome cell cycle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246026      PMCID: PMC3381281          DOI: 10.1042/BST20050981

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  23 in total

1.  Identification, purification and properties of clone-specific glycoprotein antigens constituting the surface coat of Trypanosoma brucei.

Authors:  G A Cross
Journal:  Parasitology       Date:  1975-12       Impact factor: 3.234

2.  The origin of the serum resistance associated (SRA) gene and a model of the structure of the SRA polypeptide from Trypanosoma brucei rhodesiense.

Authors:  Nuria Campillo; Mark Carrington
Journal:  Mol Biochem Parasitol       Date:  2003-03       Impact factor: 1.759

Review 3.  Antigenic variation in trypanosomes: enhanced phenotypic variation in a eukaryotic parasite.

Authors:  J D Barry; R McCulloch
Journal:  Adv Parasitol       Date:  2001       Impact factor: 3.870

4.  Trypanosoma brucei MOB1 is required for accurate and efficient cytokinesis but not for exit from mitosis.

Authors:  Tansy C Hammarton; Simon G Lillico; Sue C Welburn; Jeremy C Mottram
Journal:  Mol Microbiol       Date:  2005-04       Impact factor: 3.501

Review 5.  Implications of conserved structural motifs in disparate trypanosome surface proteins.

Authors:  M Carrington; J Boothroyd
Journal:  Mol Biochem Parasitol       Date:  1996-10-30       Impact factor: 1.759

6.  Directional movement of variable surface glycoprotein-antibody complexes in Trypanosoma brucei.

Authors:  D C Russo; D J Grab; J D Lonsdale-Eccles; M K Shaw; D J Williams
Journal:  Eur J Cell Biol       Date:  1993-12       Impact factor: 4.492

7.  Degradation, recycling, and shedding of Trypanosoma brucei variant surface glycoprotein.

Authors:  A Seyfang; D Mecke; M Duszenko
Journal:  J Protozool       Date:  1990 Nov-Dec

8.  Characterization of the ligand-binding site of the transferrin receptor in Trypanosoma brucei demonstrates a structural relationship with the N-terminal domain of the variant surface glycoprotein.

Authors:  D Salmon; J Hanocq-Quertier; F Paturiaux-Hanocq; A Pays; P Tebabi; D P Nolan; A Michel; E Pays
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

9.  Structural features affecting variant surface glycoprotein expression in Trypanosoma brucei.

Authors:  Jun Wang; Ulrike Böhme; George A M Cross
Journal:  Mol Biochem Parasitol       Date:  2003-05       Impact factor: 1.759

10.  Kinetics of endocytosis and recycling of the GPI-anchored variant surface glycoprotein in Trypanosoma brucei.

Authors:  Markus Engstler; Lutz Thilo; Frank Weise; Christoph G Grünfelder; Heinz Schwarz; Michael Boshart; Peter Overath
Journal:  J Cell Sci       Date:  2004-03-01       Impact factor: 5.285

View more
  3 in total

Review 1.  Evolution of Antigenic Variation in African Trypanosomes: Variant Surface Glycoprotein Expression, Structure, and Function.

Authors:  James D Bangs
Journal:  Bioessays       Date:  2018-10-29       Impact factor: 4.345

2.  Complexity of the MSG gene family of Pneumocystis carinii.

Authors:  Scott P Keely; James R Stringer
Journal:  BMC Genomics       Date:  2009-08-07       Impact factor: 3.969

Review 3.  Comparative Analysis of Virulence Mechanisms of Trypanosomatids Pathogenic to Humans.

Authors:  Artur Leonel de Castro Neto; José Franco da Silveira; Renato Arruda Mortara
Journal:  Front Cell Infect Microbiol       Date:  2021-04-16       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.